

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.66080541 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 6.66080541 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.49412416 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 6.49412416 |
| 5 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.93513237 |
| 6 | aromatic amino acid family catabolic process (GO:0009074) | 5.74471105 |
| 7 | negative regulation of fibrinolysis (GO:0051918) | 5.66932143 |
| 8 | alpha-linolenic acid metabolic process (GO:0036109) | 5.32763450 |
| 9 | regulation of fibrinolysis (GO:0051917) | 5.23475717 |
| 10 | high-density lipoprotein particle remodeling (GO:0034375) | 5.16401057 |
| 11 | sulfur amino acid catabolic process (GO:0000098) | 5.13810447 |
| 12 | kynurenine metabolic process (GO:0070189) | 5.13002933 |
| 13 | glyoxylate metabolic process (GO:0046487) | 5.09273178 |
| 14 | protein carboxylation (GO:0018214) | 5.08803631 |
| 15 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.08803631 |
| 16 | cysteine metabolic process (GO:0006534) | 4.99451476 |
| 17 | bile acid biosynthetic process (GO:0006699) | 4.97230483 |
| 18 | indole-containing compound catabolic process (GO:0042436) | 4.96759016 |
| 19 | indolalkylamine catabolic process (GO:0046218) | 4.96759016 |
| 20 | tryptophan catabolic process (GO:0006569) | 4.96759016 |
| 21 | urea metabolic process (GO:0019627) | 4.82509926 |
| 22 | urea cycle (GO:0000050) | 4.82509926 |
| 23 | regulation of protein activation cascade (GO:2000257) | 4.67951886 |
| 24 | tryptophan metabolic process (GO:0006568) | 4.66972450 |
| 25 | complement activation, alternative pathway (GO:0006957) | 4.58885209 |
| 26 | regulation of triglyceride catabolic process (GO:0010896) | 4.58097224 |
| 27 | reverse cholesterol transport (GO:0043691) | 4.53549307 |
| 28 | serine family amino acid catabolic process (GO:0009071) | 4.42292281 |
| 29 | nitrogen cycle metabolic process (GO:0071941) | 4.41866543 |
| 30 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.37072676 |
| 31 | regulation of complement activation (GO:0030449) | 4.36794660 |
| 32 | regulation of cholesterol esterification (GO:0010872) | 4.36670364 |
| 33 | plasma lipoprotein particle clearance (GO:0034381) | 4.35454330 |
| 34 | acylglycerol homeostasis (GO:0055090) | 4.34719730 |
| 35 | triglyceride homeostasis (GO:0070328) | 4.34719730 |
| 36 | plasma lipoprotein particle remodeling (GO:0034369) | 4.33123607 |
| 37 | protein-lipid complex remodeling (GO:0034368) | 4.33123607 |
| 38 | macromolecular complex remodeling (GO:0034367) | 4.33123607 |
| 39 | lysine metabolic process (GO:0006553) | 4.31027712 |
| 40 | lysine catabolic process (GO:0006554) | 4.31027712 |
| 41 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 4.29229260 |
| 42 | bile acid metabolic process (GO:0008206) | 4.26086083 |
| 43 | homocysteine metabolic process (GO:0050667) | 4.25220809 |
| 44 | negative regulation of cholesterol transport (GO:0032375) | 4.23536919 |
| 45 | negative regulation of sterol transport (GO:0032372) | 4.23536919 |
| 46 | phospholipid efflux (GO:0033700) | 4.23298970 |
| 47 | coenzyme catabolic process (GO:0009109) | 4.18091525 |
| 48 | NIK/NF-kappaB signaling (GO:0038061) | 4.16176011 |
| 49 | aromatic amino acid family metabolic process (GO:0009072) | 4.14624722 |
| 50 | amino-acid betaine metabolic process (GO:0006577) | 4.12153454 |
| 51 | tyrosine metabolic process (GO:0006570) | 4.11879301 |
| 52 | cellular response to type I interferon (GO:0071357) | 4.04322355 |
| 53 | type I interferon signaling pathway (GO:0060337) | 4.04322355 |
| 54 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 4.02994924 |
| 55 | response to type I interferon (GO:0034340) | 4.02849372 |
| 56 | alpha-amino acid catabolic process (GO:1901606) | 4.00247867 |
| 57 | regulation of cholesterol homeostasis (GO:2000188) | 3.96523907 |
| 58 | cellular modified amino acid catabolic process (GO:0042219) | 3.94902827 |
| 59 | positive regulation of lipid catabolic process (GO:0050996) | 3.89848867 |
| 60 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.88154458 |
| 61 | cellular ketone body metabolic process (GO:0046950) | 3.84846653 |
| 62 | fibrinolysis (GO:0042730) | 3.84432274 |
| 63 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.83434697 |
| 64 | glycine metabolic process (GO:0006544) | 3.81201101 |
| 65 | cholesterol efflux (GO:0033344) | 3.80186188 |
| 66 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.79536124 |
| 67 | glutamate metabolic process (GO:0006536) | 3.79451909 |
| 68 | myeloid dendritic cell differentiation (GO:0043011) | 3.76421537 |
| 69 | cellular amino acid catabolic process (GO:0009063) | 3.74049263 |
| 70 | ethanol oxidation (GO:0006069) | 3.73848791 |
| 71 | T-helper 1 type immune response (GO:0042088) | 3.73441630 |
| 72 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.72310493 |
| 73 | response to peptidoglycan (GO:0032494) | 3.71604937 |
| 74 | negative regulation of lipase activity (GO:0060192) | 3.67514664 |
| 75 | regulation of plasminogen activation (GO:0010755) | 3.66707609 |
| 76 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.65099965 |
| 77 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.65099965 |
| 78 | serine family amino acid metabolic process (GO:0009069) | 3.64932240 |
| 79 | plasma lipoprotein particle assembly (GO:0034377) | 3.64558819 |
| 80 | bile acid and bile salt transport (GO:0015721) | 3.62675791 |
| 81 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.62510887 |
| 82 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.61471129 |
| 83 | positive regulation of fatty acid oxidation (GO:0046321) | 3.60270206 |
| 84 | imidazole-containing compound metabolic process (GO:0052803) | 3.59962930 |
| 85 | cellular glucuronidation (GO:0052695) | 3.59933198 |
| 86 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.59651478 |
| 87 | regulation of interferon-alpha production (GO:0032647) | 3.56144738 |
| 88 | serine family amino acid biosynthetic process (GO:0009070) | 3.51720469 |
| 89 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.49630044 |
| 90 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.49467157 |
| 91 | cofactor catabolic process (GO:0051187) | 3.49406758 |
| 92 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.48300495 |
| 93 | benzene-containing compound metabolic process (GO:0042537) | 3.45637890 |
| 94 | protein-lipid complex assembly (GO:0065005) | 3.44529226 |
| 95 | arginine metabolic process (GO:0006525) | 3.44067099 |
| 96 | epoxygenase P450 pathway (GO:0019373) | 3.42876499 |
| 97 | negative regulation of interleukin-12 production (GO:0032695) | 3.42334056 |
| 98 | indolalkylamine metabolic process (GO:0006586) | 3.42069257 |
| 99 | cholesterol homeostasis (GO:0042632) | 3.41195734 |
| 100 | acetyl-CoA metabolic process (GO:0006084) | 3.40614369 |
| 101 | fatty acid beta-oxidation (GO:0006635) | 3.39142210 |
| 102 | fatty acid oxidation (GO:0019395) | 3.39053059 |
| 103 | immunoglobulin mediated immune response (GO:0016064) | 3.38619504 |
| 104 | acute-phase response (GO:0006953) | 3.38510410 |
| 105 | sterol homeostasis (GO:0055092) | 3.37518842 |
| 106 | phospholipid homeostasis (GO:0055091) | 3.36947123 |
| 107 | macrophage activation involved in immune response (GO:0002281) | 3.36108134 |
| 108 | organic acid catabolic process (GO:0016054) | 3.35477009 |
| 109 | carboxylic acid catabolic process (GO:0046395) | 3.35477009 |
| 110 | lipoprotein metabolic process (GO:0042157) | 3.34355425 |
| 111 | 2-oxoglutarate metabolic process (GO:0006103) | 3.33520922 |
| 112 | short-chain fatty acid metabolic process (GO:0046459) | 3.32933506 |
| 113 | intestinal cholesterol absorption (GO:0030299) | 3.32689027 |
| 114 | lipid oxidation (GO:0034440) | 3.31447186 |
| 115 | activation of MAPKKK activity (GO:0000185) | 3.31017915 |
| 116 | plasma lipoprotein particle organization (GO:0071827) | 3.30367688 |
| 117 | ketone body metabolic process (GO:1902224) | 3.30187260 |
| 118 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.29598215 |
| 119 | monocarboxylic acid catabolic process (GO:0072329) | 3.25770210 |
| 120 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.24469449 |
| 121 | complement activation, classical pathway (GO:0006958) | 3.23890950 |
| 122 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.23167318 |
| 123 | positive regulation of interferon-alpha production (GO:0032727) | 3.22744411 |
| 124 | germinal center formation (GO:0002467) | 3.22235383 |
| 125 | positive regulation by symbiont of host defense response (GO:0052509) | 3.21970727 |
| 126 | modulation by symbiont of host defense response (GO:0052031) | 3.21970727 |
| 127 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.21970727 |
| 128 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.21970727 |
| 129 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.21970727 |
| 130 | modulation by symbiont of host immune response (GO:0052553) | 3.21970727 |
| 131 | myeloid dendritic cell activation (GO:0001773) | 3.21446822 |
| 132 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.17587191 |
| 133 | regulation of vitamin metabolic process (GO:0030656) | 3.15778551 |
| 134 | omega-hydroxylase P450 pathway (GO:0097267) | 3.14158867 |
| 135 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.11748149 |
| 136 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.09009222 |
| 137 | positive regulation of humoral immune response (GO:0002922) | 3.04803411 |
| 138 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.04644739 |
| 139 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.03299396 |
| 140 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 3.03168732 |
| 141 | dendritic cell differentiation (GO:0097028) | 3.00621075 |
| 142 | T cell lineage commitment (GO:0002360) | 2.95712644 |
| 143 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.95545799 |
| 144 | response to muramyl dipeptide (GO:0032495) | 2.90477345 |
| 145 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.90126236 |
| 146 | regulation of mononuclear cell migration (GO:0071675) | 2.88538168 |
| 147 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.87174954 |
| 148 | regulation of chronic inflammatory response (GO:0002676) | 2.86685170 |
| 149 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.85715858 |
| 150 | glycosphingolipid catabolic process (GO:0046479) | 2.85667372 |
| 151 | response to protozoan (GO:0001562) | 2.84443097 |
| 152 | complement activation (GO:0006956) | 2.79943946 |
| 153 | modulation by symbiont of host cellular process (GO:0044068) | 2.78840224 |
| 154 | regulation of podosome assembly (GO:0071801) | 2.77327040 |
| 155 | detection of molecule of bacterial origin (GO:0032490) | 2.77067204 |
| 156 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.76627062 |
| 157 | defense response to protozoan (GO:0042832) | 2.75950311 |
| 158 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.68770885 |
| 159 | positive regulation of type 2 immune response (GO:0002830) | 2.64424162 |
| 160 | cellular response to arsenic-containing substance (GO:0071243) | 2.63736193 |
| 161 | oligosaccharide catabolic process (GO:0009313) | 2.63729455 |
| 162 | regulation of macrophage chemotaxis (GO:0010758) | 2.61672434 |
| 163 | cellular response to interferon-gamma (GO:0071346) | 2.61262414 |
| 164 | regulation of chemokine biosynthetic process (GO:0045073) | 2.61244652 |
| 165 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.61080183 |
| 166 | adhesion of symbiont to host (GO:0044406) | 2.59600155 |
| 167 | positive regulation of B cell mediated immunity (GO:0002714) | 2.59198568 |
| 168 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.59198568 |
| 169 | N-acetylneuraminate metabolic process (GO:0006054) | 2.58571043 |
| 170 | response to thyroid hormone (GO:0097066) | 2.57294175 |
| 171 | protein activation cascade (GO:0072376) | 2.57189483 |
| 172 | detection of bacterium (GO:0016045) | 2.56241038 |
| 173 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 2.55979263 |
| 174 | regulation of interleukin-12 production (GO:0032655) | 2.55605366 |
| 175 | regulation of immunoglobulin secretion (GO:0051023) | 2.55554579 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.21894950 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.31834214 |
| 3 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.63738832 |
| 4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.59551688 |
| 5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.80218624 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.56888562 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.43023864 |
| 8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.03142935 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.61235092 |
| 10 | MYC_22102868_ChIP-Seq_BL_Human | 3.26962142 |
| 11 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.17530135 |
| 12 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.14433856 |
| 13 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.89558688 |
| 14 | * VDR_21846776_ChIP-Seq_THP-1_Human | 2.88824743 |
| 15 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.78799661 |
| 16 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.65276448 |
| 17 | * IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.48370938 |
| 18 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.47687948 |
| 19 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.30933326 |
| 20 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.30651806 |
| 21 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.25216607 |
| 22 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.20233805 |
| 23 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.07441795 |
| 24 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.05122948 |
| 25 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.0620366 |
| 26 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.98928458 |
| 27 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.98729216 |
| 28 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.87796248 |
| 29 | MAF_26560356_Chip-Seq_TH1_Human | 1.86764323 |
| 30 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.80985018 |
| 31 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.78800412 |
| 32 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.78796383 |
| 33 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.75595840 |
| 34 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.67710812 |
| 35 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.66572910 |
| 36 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.65779050 |
| 37 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.64179626 |
| 38 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.63507898 |
| 39 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.60596876 |
| 40 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.59409314 |
| 41 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.56874800 |
| 42 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.54805654 |
| 43 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.47864485 |
| 44 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.46221027 |
| 45 | MAF_26560356_Chip-Seq_TH2_Human | 1.44681227 |
| 46 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.43190731 |
| 47 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.43050167 |
| 48 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.42245751 |
| 49 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.40607354 |
| 50 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.39229933 |
| 51 | UTX_26944678_Chip-Seq_JUKART_Human | 1.36756921 |
| 52 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.34754920 |
| 53 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.33769198 |
| 54 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.32569404 |
| 55 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.32281820 |
| 56 | SPI1_23127762_ChIP-Seq_K562_Human | 1.31170971 |
| 57 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.30940916 |
| 58 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.27288663 |
| 59 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.26515010 |
| 60 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.26359101 |
| 61 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.25177823 |
| 62 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.25008947 |
| 63 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.23878505 |
| 64 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.23034458 |
| 65 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.22314313 |
| 66 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.22100572 |
| 67 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.21972154 |
| 68 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.21567166 |
| 69 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.19713408 |
| 70 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.18111029 |
| 71 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.18067097 |
| 72 | MYB_26560356_Chip-Seq_TH1_Human | 1.18006783 |
| 73 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.17834566 |
| 74 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.16507416 |
| 75 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.15582157 |
| 76 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.14388839 |
| 77 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13469624 |
| 78 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.12857544 |
| 79 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.12605081 |
| 80 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11462196 |
| 81 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.10852357 |
| 82 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.10744364 |
| 83 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.10394255 |
| 84 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.09007695 |
| 85 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.08609908 |
| 86 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.07798756 |
| 87 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.07716197 |
| 88 | ATF3_27146783_Chip-Seq_COLON_Human | 1.06819097 |
| 89 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.06365568 |
| 90 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.05148739 |
| 91 | MYB_26560356_Chip-Seq_TH2_Human | 1.03469255 |
| 92 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.02843984 |
| 93 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.01535736 |
| 94 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.00284806 |
| 95 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.99216223 |
| 96 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.98323453 |
| 97 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.98312326 |
| 98 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.96684263 |
| 99 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.96522676 |
| 100 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.95987009 |
| 101 | GATA1_22025678_ChIP-Seq_K562_Human | 0.95347837 |
| 102 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.94794301 |
| 103 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.94729510 |
| 104 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.94726739 |
| 105 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.94065878 |
| 106 | P68_20966046_ChIP-Seq_HELA_Human | 0.93885964 |
| 107 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.93540211 |
| 108 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92917993 |
| 109 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.92336692 |
| 110 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.89547520 |
| 111 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.86971339 |
| 112 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.86971339 |
| 113 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.85379694 |
| 114 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.84443572 |
| 115 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.83587871 |
| 116 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.82991029 |
| 117 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.82961817 |
| 118 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.82726992 |
| 119 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.82371702 |
| 120 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.81881371 |
| 121 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.80139998 |
| 122 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.78306108 |
| 123 | GATA1_19941826_ChIP-Seq_K562_Human | 0.77497801 |
| 124 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.76522635 |
| 125 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.75742735 |
| 126 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.75665897 |
| 127 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.75600555 |
| 128 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.75034840 |
| 129 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.74191813 |
| 130 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.74134692 |
| 131 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.73542491 |
| 132 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.73542491 |
| 133 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.71930843 |
| 134 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.70598836 |
| 135 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.69972423 |
| 136 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.69965071 |
| 137 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.69696187 |
| 138 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.68600082 |
| 139 | KDM2B_26808549_Chip-Seq_K562_Human | 0.68405735 |
| 140 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.67360710 |
| 141 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.67042198 |
| 142 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.66237843 |
| 143 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.66050579 |
| 144 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.64847400 |
| 145 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.64609948 |
| 146 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.64196552 |
| 147 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.64114464 |
| 148 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.63497681 |
| 149 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.62562096 |
| 150 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.62181907 |
| 151 | GATA2_19941826_ChIP-Seq_K562_Human | 0.61155015 |
| 152 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.60931190 |
| 153 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.60040730 |
| 154 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.59617965 |
| 155 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.59511453 |
| 156 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.59259290 |
| 157 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.58542247 |
| 158 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.58422983 |
| 159 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.58109754 |
| 160 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.57501777 |
| 161 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.56333102 |
| 162 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.56246678 |
| 163 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.55681791 |
| 164 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.55249788 |
| 165 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.55240647 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.21650728 |
| 2 | MP0005360_urolithiasis | 6.20531321 |
| 3 | MP0005365_abnormal_bile_salt | 5.50308901 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 5.37350382 |
| 5 | MP0003303_peritoneal_inflammation | 4.42331982 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 4.16799147 |
| 7 | MP0003252_abnormal_bile_duct | 3.80068135 |
| 8 | MP0003806_abnormal_nucleotide_metabolis | 3.70016264 |
| 9 | MP0009840_abnormal_foam_cell | 3.36611233 |
| 10 | MP0010329_abnormal_lipoprotein_level | 3.24931527 |
| 11 | MP0003705_abnormal_hypodermis_morpholog | 3.09686046 |
| 12 | MP0005083_abnormal_biliary_tract | 3.02938487 |
| 13 | MP0003436_decreased_susceptibility_to | 2.92684838 |
| 14 | MP0009785_altered_susceptibility_to | 2.90202722 |
| 15 | MP0000685_abnormal_immune_system | 2.77413128 |
| 16 | MP0001835_abnormal_antigen_presentation | 2.75891493 |
| 17 | MP0003195_calcinosis | 2.74293122 |
| 18 | MP0005387_immune_system_phenotype | 2.71034308 |
| 19 | MP0001790_abnormal_immune_system | 2.71034308 |
| 20 | MP0002148_abnormal_hypersensitivity_rea | 2.64296711 |
| 21 | MP0008438_abnormal_cutaneous_collagen | 2.55957137 |
| 22 | MP0005000_abnormal_immune_tolerance | 2.53137226 |
| 23 | MP0004510_myositis | 2.46084851 |
| 24 | MP0005671_abnormal_response_to | 2.35118522 |
| 25 | MP0001666_abnormal_nutrient_absorption | 2.31491251 |
| 26 | MP0005332_abnormal_amino_acid | 2.28413807 |
| 27 | MP0006082_CNS_inflammation | 2.28315353 |
| 28 | MP0003191_abnormal_cellular_cholesterol | 2.25856964 |
| 29 | MP0005025_abnormal_response_to | 2.21445445 |
| 30 | MP0001800_abnormal_humoral_immune | 2.20078477 |
| 31 | MP0000609_abnormal_liver_physiology | 2.05422173 |
| 32 | MP0002419_abnormal_innate_immunity | 2.04328487 |
| 33 | MP0002118_abnormal_lipid_homeostasis | 1.98680769 |
| 34 | MP0002452_abnormal_antigen_presenting | 1.97794191 |
| 35 | MP0002723_abnormal_immune_serum | 1.94635908 |
| 36 | MP0003172_abnormal_lysosome_physiology | 1.74587916 |
| 37 | MP0004947_skin_inflammation | 1.71899227 |
| 38 | MP0005319_abnormal_enzyme/_coenzyme | 1.67346948 |
| 39 | MP0009278_abnormal_bone_marrow | 1.63144777 |
| 40 | MP0002138_abnormal_hepatobiliary_system | 1.63112996 |
| 41 | MP0003868_abnormal_feces_composition | 1.62861929 |
| 42 | MP0001845_abnormal_inflammatory_respons | 1.60951247 |
| 43 | MP0001853_heart_inflammation | 1.60521573 |
| 44 | MP0001545_abnormal_hematopoietic_system | 1.59476793 |
| 45 | MP0005397_hematopoietic_system_phenotyp | 1.59476793 |
| 46 | MP0009333_abnormal_splenocyte_physiolog | 1.58845992 |
| 47 | MP0002420_abnormal_adaptive_immunity | 1.56136004 |
| 48 | MP0001819_abnormal_immune_cell | 1.56038676 |
| 49 | MP0003075_altered_response_to | 1.53981395 |
| 50 | MP0005310_abnormal_salivary_gland | 1.53662685 |
| 51 | MP0010155_abnormal_intestine_physiology | 1.53180510 |
| 52 | MP0005275_abnormal_skin_tensile | 1.51773878 |
| 53 | MP0004019_abnormal_vitamin_homeostasis | 1.50893401 |
| 54 | MP0000343_altered_response_to | 1.45033235 |
| 55 | MP0001533_abnormal_skeleton_physiology | 1.43183144 |
| 56 | MP0003724_increased_susceptibility_to | 1.36656206 |
| 57 | MP0002405_respiratory_system_inflammati | 1.33947774 |
| 58 | MP0000716_abnormal_immune_system | 1.27911569 |
| 59 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.27376808 |
| 60 | MP0000858_altered_metastatic_potential | 1.27145429 |
| 61 | MP0002398_abnormal_bone_marrow | 1.24345240 |
| 62 | MP0005464_abnormal_platelet_physiology | 1.23626871 |
| 63 | MP0005670_abnormal_white_adipose | 1.23096260 |
| 64 | MP0002998_abnormal_bone_remodeling | 1.19563405 |
| 65 | MP0002837_dystrophic_cardiac_calcinosis | 1.17709077 |
| 66 | MP0003763_abnormal_thymus_physiology | 1.17178680 |
| 67 | MP0000598_abnormal_liver_morphology | 1.17082824 |
| 68 | MP0009643_abnormal_urine_homeostasis | 1.15614244 |
| 69 | MP0003656_abnormal_erythrocyte_physiolo | 1.15318911 |
| 70 | MP0005076_abnormal_cell_differentiation | 1.14712724 |
| 71 | MP0010368_abnormal_lymphatic_system | 1.13112057 |
| 72 | MP0000689_abnormal_spleen_morphology | 1.08884793 |
| 73 | MP0002429_abnormal_blood_cell | 1.07248519 |
| 74 | MP0004130_abnormal_muscle_cell | 1.06321466 |
| 75 | MP0005220_abnormal_exocrine_pancreas | 1.05855852 |
| 76 | MP0005451_abnormal_body_composition | 1.05042061 |
| 77 | MP0002971_abnormal_brown_adipose | 1.04653642 |
| 78 | MP0003279_aneurysm | 1.04651414 |
| 79 | MP0005503_abnormal_tendon_morphology | 0.99461362 |
| 80 | MP0002722_abnormal_immune_system | 0.99103588 |
| 81 | MP0003186_abnormal_redox_activity | 0.98086726 |
| 82 | MP0002877_abnormal_melanocyte_morpholog | 0.96604406 |
| 83 | MP0003448_altered_tumor_morphology | 0.96512913 |
| 84 | MP0009053_abnormal_anal_canal | 0.94300997 |
| 85 | MP0003091_abnormal_cell_migration | 0.94065732 |
| 86 | MP0001873_stomach_inflammation | 0.93516274 |
| 87 | MP0009384_cardiac_valve_regurgitation | 0.93396487 |
| 88 | MP0005167_abnormal_blood-brain_barrier | 0.93162283 |
| 89 | MP0002078_abnormal_glucose_homeostasis | 0.93089439 |
| 90 | MP0003011_delayed_dark_adaptation | 0.92871807 |
| 91 | MP0001764_abnormal_homeostasis | 0.92575222 |
| 92 | MP0002060_abnormal_skin_morphology | 0.91664849 |
| 93 | MP0005166_decreased_susceptibility_to | 0.91491132 |
| 94 | MP0000604_amyloidosis | 0.86968493 |
| 95 | MP0005666_abnormal_adipose_tissue | 0.86906318 |
| 96 | MP0008874_decreased_physiological_sensi | 0.85802244 |
| 97 | MP0002254_reproductive_system_inflammat | 0.85552311 |
| 98 | MP0008004_abnormal_stomach_pH | 0.83983996 |
| 99 | MP0005334_abnormal_fat_pad | 0.83962337 |
| 100 | MP0003690_abnormal_glial_cell | 0.82333876 |
| 101 | MP0001348_abnormal_lacrimal_gland | 0.79774071 |
| 102 | MP0009763_increased_sensitivity_to | 0.79602396 |
| 103 | MP0005023_abnormal_wound_healing | 0.79493026 |
| 104 | MP0004808_abnormal_hematopoietic_stem | 0.79198730 |
| 105 | MP0004185_abnormal_adipocyte_glucose | 0.78020018 |
| 106 | MP0003566_abnormal_cell_adhesion | 0.77930054 |
| 107 | MP0002332_abnormal_exercise_endurance | 0.76584257 |
| 108 | MP0009642_abnormal_blood_homeostasis | 0.76134453 |
| 109 | MP0002295_abnormal_pulmonary_circulatio | 0.75860186 |
| 110 | MP0005084_abnormal_gallbladder_morpholo | 0.75681767 |
| 111 | MP0001542_abnormal_bone_strength | 0.74580252 |
| 112 | MP0001243_abnormal_dermal_layer | 0.74098126 |
| 113 | MP0009697_abnormal_copulation | 0.73184867 |
| 114 | MP0005375_adipose_tissue_phenotype | 0.73125285 |
| 115 | MP0005257_abnormal_intraocular_pressure | 0.72994241 |
| 116 | MP0002168_other_aberrant_phenotype | 0.72402175 |
| 117 | MP0009764_decreased_sensitivity_to | 0.72310657 |
| 118 | MP0003300_gastrointestinal_ulcer | 0.71239012 |
| 119 | MP0002896_abnormal_bone_mineralization | 0.71213318 |
| 120 | MP0005647_abnormal_sex_gland | 0.68304191 |
| 121 | MP0009115_abnormal_fat_cell | 0.66337848 |
| 122 | MP0000003_abnormal_adipose_tissue | 0.66256079 |
| 123 | MP0001663_abnormal_digestive_system | 0.65917520 |
| 124 | MP0010307_abnormal_tumor_latency | 0.65897817 |
| 125 | MP0001984_abnormal_olfaction | 0.63601387 |
| 126 | MP0008260_abnormal_autophagy | 0.63453856 |
| 127 | MP0002928_abnormal_bile_duct | 0.63020049 |
| 128 | MP0005164_abnormal_response_to | 0.62615268 |
| 129 | MP0000371_diluted_coat_color | 0.62582699 |
| 130 | MP0005636_abnormal_mineral_homeostasis | 0.62536697 |
| 131 | MP0005448_abnormal_energy_balance | 0.62426113 |
| 132 | MP0004272_abnormal_basement_membrane | 0.62356142 |
| 133 | MP0006036_abnormal_mitochondrial_physio | 0.62018023 |
| 134 | MP0003183_abnormal_peptide_metabolism | 0.61749455 |
| 135 | MP0008469_abnormal_protein_level | 0.60049461 |
| 136 | MP0005376_homeostasis/metabolism_phenot | 0.60002741 |
| 137 | MP0000249_abnormal_blood_vessel | 0.59598161 |
| 138 | MP0002970_abnormal_white_adipose | 0.59593095 |
| 139 | MP0001944_abnormal_pancreas_morphology | 0.57180853 |
| 140 | MP0001756_abnormal_urination | 0.56657763 |
| 141 | MP0005058_abnormal_lysosome_morphology | 0.55784227 |
| 142 | MP0002269_muscular_atrophy | 0.54713102 |
| 143 | MP0003329_amyloid_beta_deposits | 0.53572335 |
| 144 | MP0000013_abnormal_adipose_tissue | 0.53520910 |
| 145 | MP0000639_abnormal_adrenal_gland | 0.52752417 |
| 146 | MP0001661_extended_life_span | 0.52504645 |
| 147 | MP0005535_abnormal_body_temperature | 0.51965220 |
| 148 | MP0005248_abnormal_Harderian_gland | 0.51891102 |
| 149 | MP0005395_other_phenotype | 0.49708224 |
| 150 | MP0002796_impaired_skin_barrier | 0.48649757 |
| 151 | MP0005330_cardiomyopathy | 0.47997345 |
| 152 | MP0003453_abnormal_keratinocyte_physiol | 0.45453036 |
| 153 | MP0005266_abnormal_metabolism | 0.45354584 |
| 154 | MP0003283_abnormal_digestive_organ | 0.45342409 |
| 155 | MP0009765_abnormal_xenobiotic_induced | 0.44605096 |
| 156 | MP0005408_hypopigmentation | 0.44319605 |
| 157 | MP0001958_emphysema | 0.43694988 |
| 158 | MP0005623_abnormal_meninges_morphology | 0.42952983 |
| 159 | MP0006054_spinal_hemorrhage | 0.42730938 |
| 160 | MP0005508_abnormal_skeleton_morphology | 0.42705100 |
| 161 | MP0002108_abnormal_muscle_morphology | 0.42568889 |
| 162 | MP0000767_abnormal_smooth_muscle | 0.42095059 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 6.88791492 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.37208358 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 5.90130242 |
| 4 | Xanthomatosis (HP:0000991) | 5.86278693 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.65422128 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 5.18532810 |
| 7 | Prolonged partial thromboplastin time (HP:0003645) | 5.11294547 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 4.96129242 |
| 9 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.60252476 |
| 10 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.60252476 |
| 11 | Abnormality of glycolipid metabolism (HP:0010969) | 4.60252476 |
| 12 | Complement deficiency (HP:0004431) | 4.40825755 |
| 13 | Glomerulonephritis (HP:0000099) | 4.33381038 |
| 14 | Hypolipoproteinemia (HP:0010981) | 4.28931933 |
| 15 | Hypoalphalipoproteinemia (HP:0003233) | 4.17594859 |
| 16 | Abnormality of the common coagulation pathway (HP:0010990) | 4.01120577 |
| 17 | Ketosis (HP:0001946) | 4.00727899 |
| 18 | Hypoglycemic coma (HP:0001325) | 3.98110677 |
| 19 | Hyperammonemia (HP:0001987) | 3.95256471 |
| 20 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.88757572 |
| 21 | Epidermoid cyst (HP:0200040) | 3.85661663 |
| 22 | Gastrointestinal stroma tumor (HP:0100723) | 3.83794105 |
| 23 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.81901326 |
| 24 | Hyperglycinemia (HP:0002154) | 3.77634772 |
| 25 | Joint hemorrhage (HP:0005261) | 3.72534927 |
| 26 | Protrusio acetabuli (HP:0003179) | 3.63124726 |
| 27 | Abnormality of the intrinsic pathway (HP:0010989) | 3.54458078 |
| 28 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.50216371 |
| 29 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.48997795 |
| 30 | Abnormality of complement system (HP:0005339) | 3.36607849 |
| 31 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.33821443 |
| 32 | Abnormality of glycine metabolism (HP:0010895) | 3.33821443 |
| 33 | Abnormality of macrophages (HP:0004311) | 3.31287875 |
| 34 | Hyperglycinuria (HP:0003108) | 3.30816432 |
| 35 | Premature rupture of membranes (HP:0001788) | 3.28000740 |
| 36 | Dysostosis multiplex (HP:0000943) | 3.27736970 |
| 37 | Vacuolated lymphocytes (HP:0001922) | 3.26858455 |
| 38 | Fat malabsorption (HP:0002630) | 3.23935861 |
| 39 | Increased cerebral lipofuscin (HP:0011813) | 3.20094768 |
| 40 | Ketoacidosis (HP:0001993) | 3.16291407 |
| 41 | Mediastinal lymphadenopathy (HP:0100721) | 3.15348731 |
| 42 | Myocardial infarction (HP:0001658) | 3.12016267 |
| 43 | Increased serum ferritin (HP:0003281) | 3.11056320 |
| 44 | Abnormality of methionine metabolism (HP:0010901) | 3.10205278 |
| 45 | Hypercholesterolemia (HP:0003124) | 3.09353652 |
| 46 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.09272472 |
| 47 | Peritonitis (HP:0002586) | 3.02596669 |
| 48 | Recurrent abscess formation (HP:0002722) | 3.01996925 |
| 49 | Skin nodule (HP:0200036) | 3.00235296 |
| 50 | Recurrent bacterial skin infections (HP:0005406) | 2.99345724 |
| 51 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.96496826 |
| 52 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.94819701 |
| 53 | Loss of speech (HP:0002371) | 2.87073950 |
| 54 | Eczematoid dermatitis (HP:0000976) | 2.86820031 |
| 55 | Emphysema (HP:0002097) | 2.86818950 |
| 56 | Retrobulbar optic neuritis (HP:0100654) | 2.85344472 |
| 57 | Optic neuritis (HP:0100653) | 2.85344472 |
| 58 | Meningitis (HP:0001287) | 2.84859475 |
| 59 | Orchitis (HP:0100796) | 2.81869854 |
| 60 | Purpura (HP:0000979) | 2.81048941 |
| 61 | Hyperbilirubinemia (HP:0002904) | 2.78423341 |
| 62 | Vasculitis (HP:0002633) | 2.74148142 |
| 63 | Hepatocellular carcinoma (HP:0001402) | 2.74100773 |
| 64 | Recurrent viral infections (HP:0004429) | 2.72947093 |
| 65 | Nephritis (HP:0000123) | 2.68941742 |
| 66 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.67883934 |
| 67 | Autoimmune thrombocytopenia (HP:0001973) | 2.67167625 |
| 68 | Conjugated hyperbilirubinemia (HP:0002908) | 2.65644930 |
| 69 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.56857037 |
| 70 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.56857037 |
| 71 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.56857037 |
| 72 | Cholelithiasis (HP:0001081) | 2.55833218 |
| 73 | Disinhibition (HP:0000734) | 2.54824030 |
| 74 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.54311449 |
| 75 | Abnormal gallbladder morphology (HP:0012437) | 2.53840175 |
| 76 | Hypochromic microcytic anemia (HP:0004840) | 2.53275071 |
| 77 | Mitral stenosis (HP:0001718) | 2.48204983 |
| 78 | Colitis (HP:0002583) | 2.47320439 |
| 79 | Mucopolysacchariduria (HP:0008155) | 2.46357636 |
| 80 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.46357636 |
| 81 | IgA deficiency (HP:0002720) | 2.44773150 |
| 82 | Abnormal gallbladder physiology (HP:0012438) | 2.42907555 |
| 83 | Cholecystitis (HP:0001082) | 2.42907555 |
| 84 | Abnormality of nucleobase metabolism (HP:0010932) | 2.42756050 |
| 85 | Hypoglycemic seizures (HP:0002173) | 2.42438301 |
| 86 | Late onset (HP:0003584) | 2.39655335 |
| 87 | Abnormality of serum amino acid levels (HP:0003112) | 2.37471365 |
| 88 | Spontaneous abortion (HP:0005268) | 2.37338935 |
| 89 | Abnormality of purine metabolism (HP:0004352) | 2.36978351 |
| 90 | Delayed CNS myelination (HP:0002188) | 2.34575547 |
| 91 | Amyloidosis (HP:0011034) | 2.32198863 |
| 92 | Abnormality of the Achilles tendon (HP:0005109) | 2.31883765 |
| 93 | Metabolic acidosis (HP:0001942) | 2.31368796 |
| 94 | Steatorrhea (HP:0002570) | 2.31177734 |
| 95 | Hypertensive crisis (HP:0100735) | 2.29997529 |
| 96 | Myositis (HP:0100614) | 2.29530809 |
| 97 | Abnormal cartilage morphology (HP:0002763) | 2.28746411 |
| 98 | Chronic obstructive pulmonary disease (HP:0006510) | 2.28389901 |
| 99 | Obstructive lung disease (HP:0006536) | 2.28389901 |
| 100 | Pulmonary infiltrates (HP:0002113) | 2.28338816 |
| 101 | Cardiovascular calcification (HP:0011915) | 2.28303911 |
| 102 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.25655365 |
| 103 | Neonatal onset (HP:0003623) | 2.25509260 |
| 104 | Cellulitis (HP:0100658) | 2.24463757 |
| 105 | Vascular calcification (HP:0004934) | 2.22096381 |
| 106 | Turricephaly (HP:0000262) | 2.22091550 |
| 107 | Gangrene (HP:0100758) | 2.21721291 |
| 108 | Hemorrhage of the eye (HP:0011885) | 2.20363849 |
| 109 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.20025163 |
| 110 | Dicarboxylic aciduria (HP:0003215) | 2.20025163 |
| 111 | Back pain (HP:0003418) | 2.16984567 |
| 112 | Nuclear cataract (HP:0100018) | 2.16953918 |
| 113 | Spastic diplegia (HP:0001264) | 2.15054225 |
| 114 | Increased IgM level (HP:0003496) | 2.15044355 |
| 115 | Gout (HP:0001997) | 2.11346867 |
| 116 | Agammaglobulinemia (HP:0004432) | 2.08465221 |
| 117 | Thoracic kyphosis (HP:0002942) | 2.07040606 |
| 118 | Thrombophlebitis (HP:0004418) | 2.06903264 |
| 119 | Esophageal varix (HP:0002040) | 2.06707945 |
| 120 | Increased IgE level (HP:0003212) | 2.06534564 |
| 121 | Restrictive lung disease (HP:0002091) | 2.05536852 |
| 122 | Joint swelling (HP:0001386) | 2.05293729 |
| 123 | Hyperglycemia (HP:0003074) | 2.04719231 |
| 124 | Lymphopenia (HP:0001888) | 2.04204064 |
| 125 | Recurrent sinusitis (HP:0011108) | 2.03623528 |
| 126 | Ectopia lentis (HP:0001083) | 2.03178692 |
| 127 | Malnutrition (HP:0004395) | 2.02649353 |
| 128 | Axonal loss (HP:0003447) | 2.02288160 |
| 129 | Abnormality of the gallbladder (HP:0005264) | 2.01890039 |
| 130 | Elevated alkaline phosphatase (HP:0003155) | 2.01211956 |
| 131 | Recurrent skin infections (HP:0001581) | 2.01090324 |
| 132 | Systemic lupus erythematosus (HP:0002725) | 2.00782905 |
| 133 | Abnormality of proline metabolism (HP:0010907) | 1.99824088 |
| 134 | Hydroxyprolinuria (HP:0003080) | 1.99824088 |
| 135 | Recurrent fungal infections (HP:0002841) | 1.99377163 |
| 136 | Bone pain (HP:0002653) | 1.96964755 |
| 137 | Lethargy (HP:0001254) | 1.96335772 |
| 138 | Menorrhagia (HP:0000132) | 1.95492636 |
| 139 | Abnormal delivery (HP:0001787) | 1.95332757 |
| 140 | Thin bony cortex (HP:0002753) | 1.95120001 |
| 141 | Reticulocytosis (HP:0001923) | 1.94196049 |
| 142 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.93961512 |
| 143 | Pulmonary embolism (HP:0002204) | 1.93463120 |
| 144 | Poikilocytosis (HP:0004447) | 1.92162377 |
| 145 | Keratoconjunctivitis sicca (HP:0001097) | 1.90986590 |
| 146 | Prolonged neonatal jaundice (HP:0006579) | 1.90784212 |
| 147 | Acanthocytosis (HP:0001927) | 1.90537016 |
| 148 | Arterial thrombosis (HP:0004420) | 1.90471220 |
| 149 | Recurrent lower respiratory tract infections (HP:0002783) | 1.88768200 |
| 150 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.88515260 |
| 151 | Neurofibrillary tangles (HP:0002185) | 1.88487628 |
| 152 | Irritability (HP:0000737) | 1.87293978 |
| 153 | Pancreatitis (HP:0001733) | 1.86992531 |
| 154 | Acrocyanosis (HP:0001063) | 1.86628462 |
| 155 | Biconcave vertebral bodies (HP:0004586) | 1.85986064 |
| 156 | Abnormality of iron homeostasis (HP:0011031) | 1.85391921 |
| 157 | Mitral valve prolapse (HP:0001634) | 1.84898145 |
| 158 | Recurrent bronchitis (HP:0002837) | 1.84546014 |
| 159 | Nonimmune hydrops fetalis (HP:0001790) | 1.83411799 |
| 160 | Arthralgia (HP:0002829) | 1.82889122 |
| 161 | Mutism (HP:0002300) | 1.82846623 |
| 162 | Polycythemia (HP:0001901) | 1.82641009 |
| 163 | Progressive neurologic deterioration (HP:0002344) | 1.81720282 |
| 164 | Recurrent pneumonia (HP:0006532) | 1.80828360 |
| 165 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.80648781 |
| 166 | Hemoptysis (HP:0002105) | 1.79533628 |
| 167 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.78830424 |
| 168 | Sensorimotor neuropathy (HP:0007141) | 1.78041978 |
| 169 | Opisthotonus (HP:0002179) | 1.75781097 |
| 170 | Broad metatarsal (HP:0001783) | 1.75204570 |
| 171 | Myoglobinuria (HP:0002913) | 1.72814566 |
| 172 | Gingival bleeding (HP:0000225) | 1.72206614 |
| 173 | Achilles tendon contracture (HP:0001771) | 1.70284126 |
| 174 | Vomiting (HP:0002013) | 1.70226103 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 5.40818973 |
| 2 | TRIB3 | 5.21594008 |
| 3 | IRAK3 | 4.46439826 |
| 4 | BCKDK | 4.42255073 |
| 5 | PRPF4B | 3.84739364 |
| 6 | SIK1 | 3.80742329 |
| 7 | PKN2 | 3.75252494 |
| 8 | NME2 | 3.74885563 |
| 9 | MAP3K14 | 3.11948152 |
| 10 | FGFR4 | 2.87216962 |
| 11 | MAP4K1 | 2.72822913 |
| 12 | RIPK4 | 2.70707630 |
| 13 | TAOK2 | 2.45544092 |
| 14 | SMG1 | 2.22264298 |
| 15 | LATS1 | 2.19110726 |
| 16 | TAOK3 | 2.18132703 |
| 17 | BLK | 2.07074471 |
| 18 | IRAK4 | 2.06191912 |
| 19 | PDGFRA | 1.97671451 |
| 20 | PTK6 | 1.95114537 |
| 21 | IKBKE | 1.84452899 |
| 22 | IKBKB | 1.77402393 |
| 23 | MAP3K10 | 1.77315399 |
| 24 | RIPK1 | 1.77286277 |
| 25 | MATK | 1.75821105 |
| 26 | INSRR | 1.72072703 |
| 27 | DDR2 | 1.68792932 |
| 28 | LATS2 | 1.66358233 |
| 29 | EEF2K | 1.64999016 |
| 30 | TTN | 1.62228909 |
| 31 | FLT3 | 1.61769169 |
| 32 | GRK7 | 1.50299475 |
| 33 | MAP3K13 | 1.49740063 |
| 34 | CDK12 | 1.46404179 |
| 35 | CHUK | 1.45532646 |
| 36 | CDC42BPA | 1.41356458 |
| 37 | JAK3 | 1.40415846 |
| 38 | ICK | 1.38789092 |
| 39 | BMX | 1.32312291 |
| 40 | SIK2 | 1.31987838 |
| 41 | PTK2 | 1.25956522 |
| 42 | ERBB4 | 1.25188904 |
| 43 | CSF1R | 1.24499965 |
| 44 | PIK3CG | 1.16752707 |
| 45 | DYRK1B | 1.16529972 |
| 46 | MAPK11 | 1.15687046 |
| 47 | SIK3 | 1.07973474 |
| 48 | MAPK15 | 1.07643810 |
| 49 | EPHB1 | 1.05432681 |
| 50 | ABL2 | 1.04403284 |
| 51 | FGR | 1.03638289 |
| 52 | MST1R | 1.00183697 |
| 53 | CAMK1D | 0.98944766 |
| 54 | MTOR | 0.98701846 |
| 55 | EPHA3 | 0.97042043 |
| 56 | TGFBR2 | 0.96384720 |
| 57 | CDK6 | 0.96310576 |
| 58 | NEK9 | 0.95877162 |
| 59 | EPHB2 | 0.95339139 |
| 60 | SYK | 0.94065586 |
| 61 | MAP2K4 | 0.93746878 |
| 62 | PAK3 | 0.91939135 |
| 63 | MAP3K7 | 0.91916120 |
| 64 | KIT | 0.91881393 |
| 65 | TBK1 | 0.90320893 |
| 66 | MET | 0.88439098 |
| 67 | FRK | 0.87724176 |
| 68 | MAP3K3 | 0.85619736 |
| 69 | BMPR2 | 0.84615003 |
| 70 | MAP2K3 | 0.84553792 |
| 71 | STK38L | 0.83846705 |
| 72 | IRAK2 | 0.82005444 |
| 73 | DAPK2 | 0.81958015 |
| 74 | PAK2 | 0.80764966 |
| 75 | ARAF | 0.80560867 |
| 76 | LYN | 0.79313162 |
| 77 | RET | 0.77527352 |
| 78 | MAP2K1 | 0.73970270 |
| 79 | PRKAA2 | 0.72850917 |
| 80 | LRRK2 | 0.72796454 |
| 81 | MAP3K8 | 0.68895087 |
| 82 | JAK1 | 0.67159104 |
| 83 | IRAK1 | 0.67011930 |
| 84 | FER | 0.66895114 |
| 85 | JAK2 | 0.65056175 |
| 86 | FGFR2 | 0.62813142 |
| 87 | ERBB2 | 0.62046739 |
| 88 | CAMK1G | 0.61972324 |
| 89 | PHKG2 | 0.61847968 |
| 90 | PHKG1 | 0.61847968 |
| 91 | BRAF | 0.58368140 |
| 92 | KDR | 0.58329939 |
| 93 | GSK3A | 0.56834082 |
| 94 | TYK2 | 0.56275941 |
| 95 | MAP2K2 | 0.55418226 |
| 96 | RPS6KC1 | 0.55161798 |
| 97 | RPS6KL1 | 0.55161798 |
| 98 | CLK1 | 0.54237982 |
| 99 | PRKAA1 | 0.54182351 |
| 100 | MARK3 | 0.54178087 |
| 101 | MAPKAPK3 | 0.53728798 |
| 102 | PRKD1 | 0.53593607 |
| 103 | BTK | 0.53194048 |
| 104 | PIM1 | 0.52796960 |
| 105 | DAPK3 | 0.52488329 |
| 106 | ILK | 0.51958662 |
| 107 | EPHA2 | 0.51856399 |
| 108 | STK10 | 0.51569914 |
| 109 | NTRK1 | 0.51095595 |
| 110 | STK3 | 0.49059986 |
| 111 | FGFR3 | 0.48946793 |
| 112 | PRKCH | 0.48851003 |
| 113 | ZAP70 | 0.47631505 |
| 114 | MAP3K1 | 0.46233091 |
| 115 | PRKCZ | 0.45830185 |
| 116 | MAP3K11 | 0.45409662 |
| 117 | CAMKK1 | 0.44683052 |
| 118 | TESK2 | 0.44493888 |
| 119 | PAK4 | 0.43458637 |
| 120 | MAPK12 | 0.43422978 |
| 121 | CAMK2G | 0.42835572 |
| 122 | PIM2 | 0.42762608 |
| 123 | MAPK7 | 0.41878953 |
| 124 | PRKACG | 0.41515197 |
| 125 | TYRO3 | 0.41300452 |
| 126 | RPS6KA2 | 0.40532376 |
| 127 | PDPK1 | 0.40103688 |
| 128 | CDK9 | 0.38706216 |
| 129 | PDK1 | 0.38455611 |
| 130 | HIPK2 | 0.38051662 |
| 131 | RPS6KB2 | 0.37844319 |
| 132 | CSK | 0.37821461 |
| 133 | PDGFRB | 0.37737328 |
| 134 | RPS6KA6 | 0.37631171 |
| 135 | MAP3K2 | 0.37088674 |
| 136 | FGFR1 | 0.36993067 |
| 137 | PRKD2 | 0.36133750 |
| 138 | RPS6KA4 | 0.36037419 |
| 139 | PTK2B | 0.35961918 |
| 140 | TAOK1 | 0.35777211 |
| 141 | MOS | 0.35578969 |
| 142 | MAPKAPK2 | 0.33939313 |
| 143 | LCK | 0.33775683 |
| 144 | TESK1 | 0.32964733 |
| 145 | AKT2 | 0.32659355 |
| 146 | MAPK4 | 0.32500291 |
| 147 | KSR2 | 0.32368873 |
| 148 | PRKD3 | 0.30128379 |
| 149 | CDK4 | 0.29820993 |
| 150 | MAP3K5 | 0.29672694 |
| 151 | PDK3 | 0.29374256 |
| 152 | PDK4 | 0.29374256 |
| 153 | MARK2 | 0.27602849 |
| 154 | GRK6 | 0.27381595 |
| 155 | HCK | 0.25420306 |
| 156 | MELK | 0.25059691 |
| 157 | ALK | 0.24801206 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.17555383 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.40964724 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.34927679 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.16070172 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.93030624 |
| 6 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.68916772 |
| 7 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.62760609 |
| 8 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.61503023 |
| 9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.60687607 |
| 10 | Other glycan degradation_Homo sapiens_hsa00511 | 2.60591615 |
| 11 | Allograft rejection_Homo sapiens_hsa05330 | 2.54542758 |
| 12 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.52856872 |
| 13 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.52766913 |
| 14 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.44749555 |
| 15 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.42879508 |
| 16 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.42443929 |
| 17 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.30191234 |
| 18 | Asthma_Homo sapiens_hsa05310 | 2.26661805 |
| 19 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.10922853 |
| 20 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.07052623 |
| 21 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.03482439 |
| 22 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.02725081 |
| 23 | Leishmaniasis_Homo sapiens_hsa05140 | 2.01013284 |
| 24 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.00323093 |
| 25 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.99266888 |
| 26 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.93234149 |
| 27 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.88856847 |
| 28 | Peroxisome_Homo sapiens_hsa04146 | 1.88441726 |
| 29 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.84917596 |
| 30 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.77216844 |
| 31 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.75318929 |
| 32 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.74868344 |
| 33 | Histidine metabolism_Homo sapiens_hsa00340 | 1.74863427 |
| 34 | Influenza A_Homo sapiens_hsa05164 | 1.74771476 |
| 35 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.71968340 |
| 36 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.69424712 |
| 37 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.64825607 |
| 38 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.64434883 |
| 39 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.64324002 |
| 40 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.63360668 |
| 41 | Pertussis_Homo sapiens_hsa05133 | 1.62840556 |
| 42 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.61465704 |
| 43 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.58038461 |
| 44 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.56572491 |
| 45 | Bile secretion_Homo sapiens_hsa04976 | 1.55697632 |
| 46 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.55412763 |
| 47 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.53468553 |
| 48 | Tuberculosis_Homo sapiens_hsa05152 | 1.52967857 |
| 49 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.52719158 |
| 50 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.48864199 |
| 51 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.48609708 |
| 52 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.48377148 |
| 53 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.47764591 |
| 54 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.45788023 |
| 55 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.44023230 |
| 56 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.41624033 |
| 57 | Retinol metabolism_Homo sapiens_hsa00830 | 1.39825851 |
| 58 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.36596625 |
| 59 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.34294807 |
| 60 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.32738387 |
| 61 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.31915784 |
| 62 | Measles_Homo sapiens_hsa05162 | 1.31409959 |
| 63 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.28386267 |
| 64 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.27888213 |
| 65 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.26656074 |
| 66 | Malaria_Homo sapiens_hsa05144 | 1.25617934 |
| 67 | Hepatitis C_Homo sapiens_hsa05160 | 1.25385706 |
| 68 | Carbon metabolism_Homo sapiens_hsa01200 | 1.24326361 |
| 69 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.22568958 |
| 70 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.20604337 |
| 71 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.19978537 |
| 72 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.17938513 |
| 73 | Viral myocarditis_Homo sapiens_hsa05416 | 1.17477184 |
| 74 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.14963968 |
| 75 | Sulfur relay system_Homo sapiens_hsa04122 | 1.13937248 |
| 76 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.13245369 |
| 77 | ABC transporters_Homo sapiens_hsa02010 | 1.12802285 |
| 78 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.12623245 |
| 79 | Hepatitis B_Homo sapiens_hsa05161 | 1.07309076 |
| 80 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.07294383 |
| 81 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.01613305 |
| 82 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.98797269 |
| 83 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.98620986 |
| 84 | Legionellosis_Homo sapiens_hsa05134 | 0.98228527 |
| 85 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.96971832 |
| 86 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.96162347 |
| 87 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.92090728 |
| 88 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.91683476 |
| 89 | Lysine degradation_Homo sapiens_hsa00310 | 0.90389073 |
| 90 | Apoptosis_Homo sapiens_hsa04210 | 0.89973623 |
| 91 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.88161324 |
| 92 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.83868973 |
| 93 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.83605869 |
| 94 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.81756137 |
| 95 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.79659448 |
| 96 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.77284046 |
| 97 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.76141850 |
| 98 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.75654391 |
| 99 | Salmonella infection_Homo sapiens_hsa05132 | 0.74719731 |
| 100 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.70035083 |
| 101 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.69195693 |
| 102 | Phagosome_Homo sapiens_hsa04145 | 0.66618847 |
| 103 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.65910510 |
| 104 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.64290093 |
| 105 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.63657933 |
| 106 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.63014812 |
| 107 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.62872198 |
| 108 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.60047060 |
| 109 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.59266455 |
| 110 | Insulin resistance_Homo sapiens_hsa04931 | 0.59245306 |
| 111 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.54222929 |
| 112 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.53767541 |
| 113 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.53765125 |
| 114 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.53277602 |
| 115 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.53234526 |
| 116 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.51536844 |
| 117 | Shigellosis_Homo sapiens_hsa05131 | 0.50380674 |
| 118 | Prion diseases_Homo sapiens_hsa05020 | 0.48802978 |
| 119 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.47384493 |
| 120 | HTLV-I infection_Homo sapiens_hsa05166 | 0.44103477 |
| 121 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.43982173 |
| 122 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.43343056 |
| 123 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.42442535 |
| 124 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.42358327 |
| 125 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.41568467 |
| 126 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.40836000 |
| 127 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.35896509 |
| 128 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.35391326 |
| 129 | Galactose metabolism_Homo sapiens_hsa00052 | 0.34703544 |
| 130 | Bladder cancer_Homo sapiens_hsa05219 | 0.33640452 |
| 131 | Metabolic pathways_Homo sapiens_hsa01100 | 0.33073990 |
| 132 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.32819052 |
| 133 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.32390424 |
| 134 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.21740073 |
| 135 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.20518809 |
| 136 | Amoebiasis_Homo sapiens_hsa05146 | 0.19336423 |
| 137 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.17708640 |
| 138 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.16953511 |
| 139 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.16949254 |
| 140 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.16703126 |
| 141 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.15521945 |
| 142 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.13364921 |
| 143 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.07577849 |
| 144 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.07394272 |
| 145 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.07159925 |
| 146 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.06369580 |
| 147 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.03965582 |
| 148 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.03709984 |
| 149 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.02015658 |
| 150 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.0876997 |
| 151 | mTOR signaling pathway_Homo sapiens_hsa04150 | -0.0798517 |
| 152 | Lysosome_Homo sapiens_hsa04142 | -0.0726673 |
| 153 | Proteoglycans in cancer_Homo sapiens_hsa05205 | -0.0614224 |
| 154 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | -0.0446277 |
| 155 | Focal adhesion_Homo sapiens_hsa04510 | -0.0108642 |
| 156 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0046501 |
| 157 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | -0.0034428 |

